These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 8619685)

  • 1. Topical aprotinin in cardiac operations: a note of caution.
    Ciçek S; Theodoro DA
    Ann Thorac Surg; 1996 Mar; 61(3):1039-40. PubMed ID: 8619685
    [No Abstract]   [Full Text] [Related]  

  • 2. Pro: aprotinin should be used in patients undergoing hypothermic circulatory arrest.
    Royston D
    J Cardiothorac Vasc Anesth; 2001 Feb; 15(1):121-5. PubMed ID: 11254854
    [No Abstract]   [Full Text] [Related]  

  • 3. [Commentary on the article of Dennis T. Mangano: Aprotinin and risks in cardiac surgery].
    Bizouarn P
    Ann Fr Anesth Reanim; 2006 Jul; 25(7):791-5. PubMed ID: 16839738
    [No Abstract]   [Full Text] [Related]  

  • 4. [Administration of aprotinin in surgical interventions associated with a high risk hemorrhagic complications].
    Charnaia MA; Dement'eva II
    Khirurgiia (Mosk); 2005; (11):71-6. PubMed ID: 16358454
    [No Abstract]   [Full Text] [Related]  

  • 5. A comparison before and after aprotinin was suspended in cardiac surgery: different results in the real world from a single cardiac center in China.
    Wang X; Zheng Z; Ao H; Zhang S; Wang Y; Zhang H; Li L; Hu S
    J Thorac Cardiovasc Surg; 2009 Oct; 138(4):897-903. PubMed ID: 19660368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of aprotinin in Norway.
    Bjella L; Greiff G; Pleym H; Stenseth R; Wahba A
    Acta Anaesthesiol Scand; 2007 Feb; 51(2):261; author reply 261. PubMed ID: 17261150
    [No Abstract]   [Full Text] [Related]  

  • 7. Tranexamic acid compared with high-dose aprotinin in primary elective heart operations: effects on perioperative bleeding and allogeneic transfusions.
    Casati V; Guzzon D; Oppizzi M; Bellotti F; Franco A; Gerli C; Cossolini M; Torri G; Calori G; Benussi S; Alfieri O
    J Thorac Cardiovasc Surg; 2000 Sep; 120(3):520-7. PubMed ID: 10962414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tranexamic acid and aprotinin in primary cardiac operations: an analysis of 220 cardiac surgical patients treated with tranexamic acid or aprotinin.
    Dietrich W; Spannagl M; Boehm J; Hauner K; Braun S; Schuster T; Busley R
    Anesth Analg; 2008 Nov; 107(5):1469-78. PubMed ID: 18931201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topical aprotinin in cardiac operations.
    Ciçek S
    Ann Thorac Surg; 1995 Oct; 60(4):1155. PubMed ID: 7574980
    [No Abstract]   [Full Text] [Related]  

  • 10. The impact of aprotinin on postoperative renal dysfunction in neonates undergoing cardiopulmonary bypass: a retrospective analysis.
    Guzzetta NA; Evans FM; Rosenberg ES; Fazlollah TM; Baker MJ; Wilson EC; Kaiser AM; Tosone SR; Miller BE
    Anesth Analg; 2009 Feb; 108(2):448-55. PubMed ID: 19151271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aprotinin and cardiac surgery.
    DeAnda A
    J Thorac Cardiovasc Surg; 2008 Mar; 135(3):492-4. PubMed ID: 18329458
    [No Abstract]   [Full Text] [Related]  

  • 12. Low dose aprotinin and low dose tranexamic acid in elective cardiac surgery with cardiopulmonary bypass.
    Waldow T; Krutzsch D; Wils M; Plötze K; Matschke K
    Clin Hemorheol Microcirc; 2009; 42(4):269-77. PubMed ID: 19628892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aprotinin and renal function at cardiac surgery.
    McBride WT; Allen JS; Armstrong MA
    Eur J Anaesthesiol; 2006 Mar; 23(3):261-2; author reply 262. PubMed ID: 16430799
    [No Abstract]   [Full Text] [Related]  

  • 14. Con: Aprotinin should not be used in cardiac surgery with cardiopulmonary bypass.
    Augoustides JG
    J Cardiothorac Vasc Anesth; 2007 Apr; 21(2):302-4. PubMed ID: 17418754
    [No Abstract]   [Full Text] [Related]  

  • 15. Con: Aprotinin has a good efficacy and safety profile relative to other alternatives for prevention of bleeding in cardiac surgery.
    Beattie WS; Karkouti K
    Anesth Analg; 2006 Dec; 103(6):1360-4. PubMed ID: 17122203
    [No Abstract]   [Full Text] [Related]  

  • 16. Con: aprotinin should not be used in patients undergoing hypothermic circulatory arrest.
    Gravlee GP
    J Cardiothorac Vasc Anesth; 2001 Feb; 15(1):126-8. PubMed ID: 11254855
    [No Abstract]   [Full Text] [Related]  

  • 17. [Aprotinin in cardiac surgery: one paper of the year or a provocation from the New England Journal of Medicine].
    Blanloeil Y
    Ann Fr Anesth Reanim; 2006 Jul; 25(7):683-5. PubMed ID: 16919751
    [No Abstract]   [Full Text] [Related]  

  • 18. [Aprotinin in the control of surgical hemorrhage].
    Rocha E; Antonio Páramo J; Hermida J
    Med Clin (Barc); 1996 Mar; 106(8):307-16. PubMed ID: 8667690
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effects of topical applications of aprotinin and tranexamic acid on blood loss after open heart surgery].
    Yasim A; Aşik R; Atahan E
    Anadolu Kardiyol Derg; 2005 Mar; 5(1):36-40. PubMed ID: 15755701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aprotinin in cardiac surgery: a review of conventional and novel mechanisms of action.
    McEvoy MD; Reeves ST; Reves JG; Spinale FG
    Anesth Analg; 2007 Oct; 105(4):949-62. PubMed ID: 17898372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.